3 During these trials, which investigated the utility of these drugs for glycemic control, GLP-1RAs showed a secondary benefit of weight reduction, which has led to their recent approval for weight management in several countries worldwide
Treatment trusted by thousands Image-conscious Los Angeles demands results that show both in photos and in person without excuses or delays
Injection protocols and timing Separate injections: Semaglutide: Subcutaneous, abdomen or thigh Cagrilintide: Subcutaneous, different site Same day, different locations Both weekly Timing considerations: Most take both same day (simplicity) Can split: Semaglutide Monday, Cagrilintide Thursday No evidence one timing superior Choose based on preference Injection technique: Standard subcutaneous injection 29-31 gauge needles Rotate injection sites No special requirements See our peptide injections guide , how to calculate peptide dosages , and how to reconstitute peptides if using research peptides
According to Elara Securities, the company has a massive 15% market share in the diabetes segment
The FDA has continued revising the label since: January 28, 2025 added acute kidney injury and severe gastrointestinal reaction warnings along with not recommended in patients with severe gastroparesis, and October 14, 2025 strengthened the pancreatitis warnings
He prescribes GLP-1 drugs, and he's candid about their limits
